Galenical formulations of a fixed dose combination of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/00 (2006.01) A61K 9/20 (2006.01)

Patent

CA 2755487

The present invention relates to a pharmaceutical oral fixed dose combination comprising: a) a therapeutically ef-fective amount of Aliskiren, or a pharmaceutically acceptable salt thereof, b) a therapeutically effective amount of Valsartan, or a pharmaceutically acceptable salt thereof, c) a disintegrant, and d) a further disintegrant being a polysaccharide.

La présente invention concerne une combinaison de dose fixe orale pharmaceutique comprenant : a) une quantité thérapeutiquement efficace d'Aliskiren, ou un sel pharmaceutiquement acceptable de celui-ci, b) une quantité thérapeutiquement efficace de Valsartan, ou un sel pharmaceutiquement acceptable de celui-ci, c) un délitant, et d) un délitant supplémentaire étant un polysaccharide.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Galenical formulations of a fixed dose combination of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Galenical formulations of a fixed dose combination of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galenical formulations of a fixed dose combination of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1765527

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.